Hyde Park Capital Advises Emerald Coast Infectious Disease on its Sale to RCap Equity

Hyde Park Capital announced today that its client, Emerald Coast Infectious Disease (“ECID”), a full-service provider of infectious disease care, infusion services, and wound care treatment located in Fort Walton Beach and Crestview, FL, has been acquired by RCap Equity Partners (“RCap”), a middle-market private equity firm based in Wayne, PA. Hyde Park Capital served as the exclusive investment banker to ECID for this transaction. Carlton Fields served as legal counsel to ECID.

Dr. Patrick Anastasio, Owner and Head Physician of Emerald Coast Infectious Disease, said “I am extremely excited to partner with RCap and take ECID to the next level. With ECID’s exceptional care and RCap’s aptitude for growth, I believe we can become the premier provider of infectious disease care throughout the entire Florida Panhandle.”

Regarding Hyde Park’s services, Dr. Anastasio also said “the Hyde Park team was intricate in finding ECID the best deal. Their professional experience and knowledge helped us navigate through the process, which at times was arduous. Josh, John, and the rest of the HPC team were there with us every step of the way and we would recommend them to any physician practice contemplating a partnership. We are extremely grateful for their services and so glad we chose HPC to be our investment banker.”

Randall Kutch, General Partner of RCap Equity Partners, said “We are extremely excited to partner with Dr. Anastasio and the ECID team. ECID’s focus on providing quality care to their patients was a main driver in our interest in partnering. I believe we can leverage Dr. Anastasio’s experience and prestige in infectious disease and infusion therapy to create a regional platform.”

John McDonald, Senior Managing Director of Hyde Park Capital, said “We are thrilled to have had the opportunity to represent the leading provider of full-service infectious disease care to the Emerald Coast of Florida. Dr. Anastasio is a thought leader in the infectious disease specialty and will be a great partner for RCap.”

The partnership of RCap and ECID marks the first private equity investment in the infectious disease specialty. The infectious disease specialty is extremely fragmented, comprised of many groups of private doctors. This, paired with the macro tailwinds such as an aging population, makes infectious disease poised for consolidation.

About Emerald Coast Infectious Disease

Emerald Coast Infectious Disease, founded 17 years ago by Dr. Patrick Anastasio, is the premier provider of infectious disease care in the Emerald Coast of Florida. ECID specializes in the treatment of diseases such as MRSA, Tuberculosis, HIV/AIDS, HepC, travel health, tropical diseases, and common infections of the skin, lungs, kidneys, bones, and blood. With locations in Fort Walton Beach and Crestview, and a new location opening in Panama City Beach, ECID provides a full suite of services to residents along the Florida Panhandle. For additional information, please visit www.infectionclinic.com.

About RCap Equity Partners

RCap Equity Partners makes control equity investments and select minority investments in lower middle market companies. The firm is an active investor in profitable and growing enterprises.  The RCap team, in partnership with management, seeks to create value through operational improvements, strategic growth initiatives, and acquisitions. More information on RCap and its portfolio companies can be found at www.rcapequity.com.

About Hyde Park Capital

Hyde Park Capital is an institutionally focused boutique investment banking firm specializing in mergers and acquisitions and focusing on serving the corporate finance needs of successful founder and family-owned companies. Hyde Park’s principals have extensive investment banking experience managing merger and acquisition engagements, including executing sell-side and buy-side sale of company assignments, recapitalizations, financial advisory services, fairness opinions, and raising growth capital and acquisition financing for companies, including equity, mezzanine, and senior debt. Hyde Park Capital has extensive experience across numerous industry sectors, including industrial, technology, healthcare, business, and financial services. Hyde Park Capital is headquartered in Tampa, Florida, and is a member of FINRA and SIPC. Hyde Park Capital is also a member of the Geneva Capital Group (GCG) International M&A Alliance (see www.gcg.com).


Media Contacts:

John M. McDonald III
Hyde Park Capital

Joshua Paul
Hyde Park Capital